Multicomponent Breath Analysis With Infrared Absorption Using Room-Temperature Quantum Cascade Lasers

IEEE Sensors Journal

Volumn 10, Issue 1, 2010, Pages 76-84

  Shorter, Joanne H ^a   Nelson, David D ^a   McManus, J Barry ^a   Zahniser, Mark S ^a   Milton, Donald K ^b  

^a AERODYNE RESEARCH INC   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Infrared spectroscopy; nitric oxide; quantum cascade laser

Indexed keywords

EID: 85008060922     PISSN: 1530437X     EISSN: 15581748     Source Type: Journal    
DOI: 10.1109/JSEN.2009.2035764     Document Type: Article

References (43)

1. P. Silkoff, “History, technical and regulatory aspects of exhaled nitric oxide,” J. Breath Res., vol. 2, pp. 037001–037008, 2008.
2. U.S. Dept. of Health and Human Services, 2004, vol. 2004 [Online]. Available: http://www.nhlbi.nih.gov/health/dci/Diseases/Asthma
3. Chronic Obstructive Pulmonary Disease—Data Fact Sheet, NIH Publication-5229. Washington, DC: US Dept. of Health and Human Services and NIH, 2003, pp. 1–6.
4. L. G. Wood, P. G. Gibson, and M. L. Garg, “Biomarkers of lipid peroxidation, airway inflammation and asthma,” Eur. Respir. J., vol. 21, pp. 177–186, 2003.
5. S. A. Kharitonov and P. J. Barnes, “Exhaled markers of pulmonary disease,” Am. J. Respir. Crit. Care Med., vol. 163, pp. 1693–1722, 2001.
6. P. Paredi, S. A. Kharitonov, and P. J. Barnes, “Analysis of expired air for oxidation products,” Amer. J. Respir. Crit. Care Med., vol. 166, pp. 531–537, 2002.
7. L. P. Malmberg, A. S. Pelkonen, T. Haahtela, and M. Turpeinen, “Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma,” Thorax, vol. 58, pp. 494–499, 2003.
8. P. E. Silkoff, F. A. Romero, N. Gupta, R. G. Townley, and H. Milgrom, “Exhaled nitric oxide in children with asthma receiving xolair (Omalizumab), a monoclonal anti-immunoglobulin E antibody,” Pediatrics, vol. 113, pp. 308–312, 2004.
9. B. Mahut, C. Delacourt, F. Zerah-Lancner, J. De Blic, A. Harf, and C. Delclaux, “Increase in alveolar nitric oxide in the presence of symptoms in childhood asthma,” Chest, vol. 125, pp. 1012–1018, 2004.
10. K. Zayasu, K. Sekizawa, S. Okinage, M. Yamaya, T. Ohrui, and H. Sasaki, “Increased carbon monoxide in exhaled air of asthmatic patients,” Amer. J. Respir. Crit. Care Med., vol. 156, pp. 1140–1143, 1997.
11. P. Paredi, P. L. Shah, P. Montuschi, P. Sullivan, M. E. Hodson, S. A. Kharitonov, and P. J. Barnes, “Increased carbon monoxide in exhaled air of patients with cystic fibrosis,” Thorax, vol. 54, pp. 917–920, 1999.
12. J. D. Antuni, S. A. Kharitonov, D. Hughes, M. E. Hodson, and P. J. Barnes, “Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis,” Thorax, vol. 55, pp. 138–142, 2000.
13. P. Montuschi, S. A. Kharitonov, and P. J. Barnes, “Exhaled carbon monoxide and nitric oxide in COPD,” Chest, vol. 120, pp. 496–501, 2001.
14. M. Hogman and P. Meriläinen, “Extended NO analysis in asthma,” J. Breath Res., vol. 1, pp. 024001–024008, 2007.
15. S. C. George, M. Hogman, S. Permutt, and P. E. Silkoff, “Modeling pulmonary nitric oxide exchange,” J. Appl. Physiol., vol. 96, pp. 831–839, 2004.
16. H. W. Shin, P. Condorelli, and S. C. George, “A new and more accurate technique to characterize airway nitric oxide using different breathhold times,” J. Appl. Physiol., vol. 98, pp. 1869–1877, 2005.
17. P. E. Silkoff, J. T. Sylvester, N. Zamel, and S. Permutt, “Airway nitric oxide diffusion in asthma,” Am. J. Respir. Crit. Care Med., vol. 161, pp. 1218–1228, 2000.
18. N. M. Tsoukias, H. W. Shin, A. F. Wilson, and S. C. George, “A single-breath technique with variable flow rate to characterize nitric oxide exchange dynamics in the lungs,” J. Appl. Physiol., vol. 91, pp. 477–487, 2001.
19. 2 in humans: Effect of dynamically changing flow rate,” J. Appl. Physiol., vol. 85, pp. 642–652, 1998.
20. A. Deykin, A. F. Massaro, J. M. Drazen, and E. Israel, “Exhaled nitric oxide as a diagnostic test for asthma,” Amer. J. Respir. Crit. Care Med., vol. 165, pp. 1597–1601, 2002.
21. P. Condorelli, H. W. Shin, and S. C. George, “Characterizing airway and alveolar nitric oxide exchange during tidal breathing using a three-compartment model,” J. Appl. Physiol., vol. 96, pp. 1832–1842, 2004.
22. L. Lehtimaki, H. Kankaanranta, S. Saarelainen, P. Hahtola, R. Jarvenpaa, T. Koivula, V. Turjanmaa, and E. Moilanen, “Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation,” Amer. J. Respir. Crit. Care Med., vol. 163, pp. 1557–1561, 2001.
23. K. Namjou, P. J. McCann, and W. T. Potter, “Breath testing with a Mid-IR laser spectrometer,” Application of Tunable Diode and Other Infrared Sources for Atmospheric Studies and Industrial Processing Monitoring II, Proc. SPIE, pp. 74–80, 1999.
24. L. Konstantin, A. I. Nadezhdinskii, and I. A. Adamouskaya, “Human breath trace gas content study by tunable diode laser spectroscopy technique,” Infrared Phys. Technol., vol. 37, pp. 181–192, 1996.
25. K. Namjou, C. B. Roller, T. E. Reich, J. D. Jeffers, G. L. McMillen, P. J. McCann, and M. A. Camp, “Determination of exhaled nitric oxide distributions in a diverse sample population using tunable diode laser absorption spectroscopy,” Appl. Phys. B., vol. 85, pp. 427–435, 2006.
26. C. Roller, K. Namjou, J. D. Jeffers, M. Camp, A. Mock, P. J. McCann, and J. Grego, “Nitric oxide breath testing by tunable-diode laser absorption spectroscopy: Application in monitoring respiratory inflammation,” Appl. Opt., vol. 41, pp. 6018–6029, 2002.
27. A. A. Kosterev, A. L. Malinovsky, F. K. Tittel, C. Gmachl, F. Capasso, D. L. Sivco, J. N. Baillargeon, A. L. Hutchinson, and A. Y. Cho, “Cavity ringdown spectroscopic detection of nitric oxide with continuous-wave quantum cascade laser,” Appl. Opt., vol. 40, pp. 5522–5529, 2001.
28. A. A. Kosterev and F. K. Tittel, “Chemical sensors based on quantum cascade lasers,” IEEE J. Quantum Electron., vol. 38, no. 6, pp. 582–591, Jun. 2002.
29. Y. A. Bakhirkin, A. A. Kosterev, R. F. Curl, F. K. Tittel, D. A. Yarekha, L. Hvozdara, M. Giovannini, and J. Faist, “Sub-ppbv nitric oxide concentration measurements using cw thermoelectrically cooled quantum cascade laser-based integrated cavity output spectroscopy,” Appl. Opt. B, vol. 82, pp. 149–154, 2006.
30. Y. A. Bakhirkin, A. A. Kosterev, C. Roller, R. F. Curl, and F. K. Tittel, “Mid-infrared quantum cascade laser based off-axis integrated cavity output spectroscopy for biogenic nitric oxide detection,” Appl. Opt., vol. 43, pp. 2257–2266, 2004.
31. T. Fritsch, P. Hering, and M. Mürtz, “Infrared laser spectroscopy for online recording of exhaled carbon monoxide—a progress report,” J. Breath Res., vol. 1, pp. 014002–014009, 2007.
32. A. A. Kosterev, F. K. Tittel, W. Durante, M. Allen, R. Kohler, C. Gmachl, F. Capasso, D. L. Sivco, and A. Y. Cho, “Detection of biogenic CO production above vascular cell cultures using a near-room-temperature QC-DFB laser,” Appl. Phys. B, vol. 74, pp. 95–99, 2002.
33. B. W. M. Moeskops, H. Naus, S. M. Cristescu, and F. J. M. Harren, “Quantum cascade laser-based carbon monoxide detection on a second time scale from human breath,” Appl. Phys. B, vol. 82, pp. 649–654, 2006.
34. J. Faist, F. Capasso, D. L. Sivco, C. Sirtori, A. F. Hutchinson, and A. Y. Cho, “Quantum cascade Faser; plus associated news article,” Science, vol. 264, p. 508, 1994.
35. F. Capasso, C. Gmachl, A. Tredicucci, A. L. Hutchinson, and A. Y. Cho, “High performance quantum cascade lasers,” Opt. Photon. News, pp. 31–37, Oct. 1999.
36. F. Capasso, C. Gmachl, D. L. Sivco, and A. Y. Cho, “Quantum cascade lasers,” Phys. Today, pp. 33–40, May 2002.
37. J. B. McManus, J. H. Shorter, D. D. Nelson, M. S. Zahniser, D. E. Glenn, and R. M. McGovern, “Pulsed quantum cascade laser instrument with compact design for rapid, high sensitivity measurements of trace gases in air,” Appl. Phys. B, vol. 92, pp. 387–392, 2008.
38. American Thoracic Society and European Respiratory Society, “ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric Oxide, 2005,” Amer. J. Crit. Care Med, vol. 171, pp. 912–930, 2005.
39. P. McCann, K. Namjou, C. Roller, G. McMillen, and P. Kamat, “IV-VI semiconductor lasers for gas phase biomarker detection,” Proc. SPIE, vol. 6756, pp. 675603-1–675603-112, 2007.
40. M. A. Kamboures, D. R. Blake, D. M. Cooper, R. L. Newcomb, M. Barker, J. K. Farson, S. Meinardi, E. Nussbaum, and F. S. Rowland, “Breath sulfides and pulmonary function in cystic fibrosis,” Proc. Nat. Acad. Sci., vol. 102, pp. 15762–15767, 2005.
41. M. D. Knutson, G. J. Handelman, and F. E. Viteri, “Methods for measuring ethane and pentane in expired air from rats and humans,” Free Radic. Biol. Med., vol. 28, pp. 514–519, 2000.
42. P. Paredi, S. A. Kharitonov, and P. J. Barnes, “Elevation of exhaled ethane concentration in asthma,” Amer. J. Respir. Crit. Care Med., vol. 162, pp. 1450–1454, 2000.
43. P. Paredi, S. A. Kharitonov, D. Leak, S. Ward, D. Cramer, and P. J. Barnes, “Exhaled ethane, a marker of lipid peroxidaton, is elevated in chronic obstructive pulmonary disease,” Amer. J. Respir. Crit. Care Med., vol. 162, pp. 369–373, 2000.